Study for people who suffer from ankylosing spondyloarthritis
Who are we?
It takes about 12 years of research and development before a new medication is put on the market. Each medication must undergo an extensive testing process to ensure that it is both safe and effective. Humans are only involved in the very last steps of this long process, through clinical testing.
At Alta, we mainly conduct trials for generic formulations (copies) of medications which are already on the market, but we also conduct trials for new medications.
Participants are crucial to medical research. Without them, no new medication could be approved or improved.
Information About The Current Study
Who are we Seeking?
We are seeking men and women, aged 18 to 50, who suffer from ankylosing spondyloarthritis, to participate in study K64 in Montreal. Book an appointment at our medical centre and receive at no cost a medical exam. We will be able to give you an overall health assessment, which will allow you to discover your eligibility for this clinical study.
How are participants compensated for this study?
Receive up to $5,500 for your participation.
How long is the study?
The study includes a single stay of 5 days. All of the details will be explained by one of our agents over the phone.
What are the advantages of taking part in this study?
By taking part in this study, you will be helping the development of a medication type which could eventually be part of the solution to the treatment of ankylosing spondyloarthritis.
In addition, you will be compensated for your time and travel.